Dexlansoprazole
TAK-390MR_108
Phase 1 small_molecule terminated
Quick answer
Dexlansoprazole for Pediatric Gastroesophageal Reflux Disease is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Pediatric Gastroesophageal Reflux Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated